inactivated virus vaccine

Covaxin Is 50% Effective, New Study Says. What Does That Mean Exactly?

Bharat Biotech Releases Long-Awaited Covaxin Phase 3 Data, Claims 77.8% Efficacy

France, Germany Pause AstraZeneca Rollouts Over Sporadic Blood Clot Reports